NEW YORK (GenomeWeb) – A pricing agreement announced today at the 2018 International AIDS Conference is expected to significantly reduce the cost of diagnostic testing for HIV/AIDS, hepatitis, and cervical cancer for millions of people.

Under the agreement, public sector programs in Zambia, Malawi, Tanzania, Uganda, and Zimbabwe will obtain access to Hologic's integrated molecular Panther system at $12 per patient sample and without paying upfront costs or investing in capital equipment.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.